Literature DB >> 16723519

Molecular composition of the endocannabinoid system at glutamatergic synapses.

István Katona1, Gabriella M Urbán, Matthew Wallace, Catherine Ledent, Kwang-Mook Jung, Daniele Piomelli, Ken Mackie, Tamás F Freund.   

Abstract

Endocannabinoids play central roles in retrograde signaling at a wide variety of synapses throughout the CNS. Although several molecular components of the endocannabinoid system have been identified recently, their precise location and contribution to retrograde synaptic signaling is essentially unknown. Here we show, by using two independent riboprobes, that principal cell populations of the hippocampus express high levels of diacylglycerol lipase alpha (DGL-alpha), the enzyme involved in generation of the endocannabinoid 2-arachidonoyl-glycerol (2-AG). Immunostaining with two independent antibodies against DGL-alpha revealed that this lipase was concentrated in heads of dendritic spines throughout the hippocampal formation. Furthermore, quantification of high-resolution immunoelectron microscopic data showed that this enzyme was highly compartmentalized into a wide perisynaptic annulus around the postsynaptic density of axospinous contacts but did not occur intrasynaptically. On the opposite side of the synapse, the axon terminals forming these excitatory contacts were found to be equipped with presynaptic CB1 cannabinoid receptors. This precise anatomical positioning suggests that 2-AG produced by DGL-alpha on spine heads may be involved in retrograde synaptic signaling at glutamatergic synapses, whereas CB1 receptors located on the afferent terminals are in an ideal position to bind 2-AG and thereby adjust presynaptic glutamate release as a function of postsynaptic activity. We propose that this molecular composition of the endocannabinoid system may be a general feature of most glutamatergic synapses throughout the brain and may contribute to homosynaptic plasticity of excitatory synapses and to heterosynaptic plasticity between excitatory and inhibitory contacts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16723519      PMCID: PMC1698282          DOI: 10.1523/JNEUROSCI.0309-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

1.  Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons.

Authors:  I Katona; B Sperlágh; A Sík; A Käfalvi; E S Vizi; K Mackie; T F Freund
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

2.  Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus.

Authors:  Judit K Makara; Marco Mor; Darren Fegley; Szilárd I Szabó; Satish Kathuria; Giuseppe Astarita; Andrea Duranti; Andrea Tontini; Giorgio Tarzia; Silvia Rivara; Tamás F Freund; Daniele Piomelli
Journal:  Nat Neurosci       Date:  2005-08-07       Impact factor: 24.884

Review 3.  Dendritic spines and long-term plasticity.

Authors:  Menahem Segal
Journal:  Nat Rev Neurosci       Date:  2005-04       Impact factor: 34.870

4.  The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction.

Authors:  A Baude; Z Nusser; J D Roberts; E Mulvihill; R A McIlhinney; P Somogyi
Journal:  Neuron       Date:  1993-10       Impact factor: 17.173

Review 5.  Evidence for novel cannabinoid receptors.

Authors:  Malcolm Begg; Pál Pacher; Sándor Bátkai; Douglas Osei-Hyiaman; László Offertáler; Fong Ming Mo; Jie Liu; George Kunos
Journal:  Pharmacol Ther       Date:  2005-01-11       Impact factor: 12.310

6.  Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal.

Authors:  Yuki Hashimotodani; Takako Ohno-Shosaku; Hiroshi Tsubokawa; Hidenori Ogata; Ken Emoto; Takashi Maejima; Kenji Araishi; Hee-Sup Shin; Masanobu Kano
Journal:  Neuron       Date:  2005-01-20       Impact factor: 17.173

7.  Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites.

Authors:  R Luján; J D Roberts; R Shigemoto; H Ohishi; P Somogyi
Journal:  J Chem Neuroanat       Date:  1997-10       Impact factor: 3.052

8.  Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation.

Authors:  K Tsou; K Mackie; M C Sañudo-Peña; J M Walker
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

9.  Functional role of high-affinity anandamide transport, as revealed by selective inhibition.

Authors:  M Beltramo; N Stella; A Calignano; S Y Lin; A Makriyannis; D Piomelli
Journal:  Science       Date:  1997-08-22       Impact factor: 47.728

10.  Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

Authors:  C Ledent; O Valverde; G Cossu; F Petitet; J F Aubert; F Beslot; G A Böhme; A Imperato; T Pedrazzini; B P Roques; G Vassart; W Fratta; M Parmentier
Journal:  Science       Date:  1999-01-15       Impact factor: 47.728

View more
  225 in total

1.  The interaction between hippocampal GABA-B and cannabinoid receptors upon spatial change and object novelty discrimination memory function.

Authors:  Mohammad Nasehi; Niyousha Alaghmandan-Motlagh; Mohaddeseh Ebrahimi-Ghiri; Mohammad Nami; Mohammad-Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2017-08-05       Impact factor: 4.530

2.  Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.

Authors:  Vasco C Sousa; Natália Assaife-Lopes; Joaquim A Ribeiro; Judith A Pratt; Ros R Brett; Ana M Sebastião
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

3.  Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus.

Authors:  Sang-Hun Lee; Csaba Földy; Ivan Soltesz
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 4.  Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output.

Authors:  Megan L Fitzgerald; Eli Shobin; Virginia M Pickel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-11       Impact factor: 5.067

5.  Distinct coincidence detectors govern the corticostriatal spike timing-dependent plasticity.

Authors:  Elodie Fino; Vincent Paille; Yihui Cui; Teresa Morera-Herreras; Jean-Michel Deniau; Laurent Venance
Journal:  J Physiol       Date:  2010-07-05       Impact factor: 5.182

6.  Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.

Authors:  Vincenzo Di Marzo
Journal:  Nat Neurosci       Date:  2011-01       Impact factor: 24.884

Review 7.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

8.  Altered dendritic distribution of dopamine D2 receptors and reduction in mitochondrial number in parvalbumin-containing interneurons in the medial prefrontal cortex of cannabinoid-1 (CB1) receptor knockout mice.

Authors:  Megan L Fitzgerald; June Chan; Kenneth Mackie; Carl R Lupica; Virginia M Pickel
Journal:  J Comp Neurol       Date:  2012-12-01       Impact factor: 3.215

9.  Diacylglycerol lipase-alpha and -beta control neurite outgrowth in neuro-2a cells through distinct molecular mechanisms.

Authors:  Kwang-Mook Jung; Giuseppe Astarita; Dean Thongkham; Daniele Piomelli
Journal:  Mol Pharmacol       Date:  2011-04-14       Impact factor: 4.436

10.  The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons.

Authors:  Silvia Marinelli; Simone Pacioni; Tiziana Bisogno; Vincenzo Di Marzo; David A Prince; John R Huguenard; Alberto Bacci
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.